is semaglutide still on shortage list As of February 21, 2025, the FDA updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A Explainer: What's behind the scramble

Customized medications tailored to your unique needs, offering personalized solutions for wellness, balance, and long-term health

Most patients stay on it for 612+ months as they build sustainable habits and achieve their goals

Abstract Purpose of Review This review summarizes recent advances in the clinical applications of glucagon-like peptide-1 receptor agonists (GLP-1RAs) beyond their established role in glycemic control for type 2 diabetes (T2DM)

Sharma emphasizes portion control to avoid overeating

Similar content being viewed by others Introduction Glucagon-like peptide-1 receptor agonists (GLP1-RAs) are an effective class of drugs for the treatment of type 2 diabetes mellitus (T2D), with well-defined safety and tolerability profiles